Citigroup Inc Axsome Therapeutics, Inc. Call Options Transaction History

Citigroup Inc

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$78.93 - $95.84 $1.97 Million - $2.4 Million	25,000 New	25,000 $2.25 Million
Q3 2023 Nov 09, 2023	BUY	$69.25 - $82.21 $1.9 Million - $2.25 Million	27,400 New	27,400 $1.91 Million
Q2 2022 Aug 10, 2022	BUY	$21.74 - $46.75 $550,022 - $1.18 Million	25,300 New	25,300 $969,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.